Skip to content

drug development pipeline

With the patient constantly on our minds, we are focusing on delivering the benefits of transdermal drug delivery and improving their quality of life. We do so by either increasing the effectiveness of the treatment with a needle-free administration and a much more constant and sustained drug level, or by reducing drug levels and side-effects with a much more targeted delivery and increased bioavailability.


We transport through the skin lipophilic and hydrophilic substances.
That gives an opportunity for the patients for efficient and convenient treatment in many therapeutic areas such as:

development collaborations

The MTC-Y™ carrier technology is the foundation of Biotts’ transdermal drug product development
pipeline, but it’s also available to the pharmaceutical industry through contract development
collaborations. Contact us or further information.